1. Musa Sultan M, Hussein Abdullah T, Abbas Abdullah M, Al-Darkazali W, Sattar Harbi N. Evaluate the Serum of Irisin, Omentin-1, and Oxidative Status in Males with Prostatic Cancer. Rep Biochem Mol Biol. 2024;13(1):23-30. [
DOI:10.61186/rbmb.13.1.23] [
PMID] [
]
2. Ahmadzadeh A, Khodayar MJ, Salehcheh M, Nazari Khorasgani Z, Matin M. Evaluation of the Total Oxidant Status to the Antioxidant Capacity Ratio as a Valuable Biomarker in Breast Cancer Patients. Rep Biochem Mol Biol. 2023;12(2):277-283. [
DOI:10.61186/rbmb.12.2.277] [
PMID] [
]
3. Ng EH, Gao F, Ji CY, Ho GH, Soo KC. Risk factors for breast carcinoma in Singaporean Chinese women: the role of central obesity. Cancer. 1997;80(4):725-31.
https://doi.org/10.1002/(SICI)1097-0142(19970815)80:4<725::AID-CNCR11>3.0.CO;2-V [
DOI:10.1002/(SICI)1097-0142(19970815)80:43.0.CO;2-V]
4. Gallegos-Arreola MP, Figuera-Villanueva LE, Ramos-Silva A, Salas-González E, Puebla-Pérez AM, Peralta-Leal V, et al. The association between the 844ins68 polymorphism in the CBS gene and breast cancer. Arch Med Sci. 2014;10(6):1214-24. [
DOI:10.5114/aoms.2014.47830] [
PMID] [
]
5. de Jong MM, Nolte IM, te Meerman GJ, van der Graaf WT, Oosterwijk JC, Kleibeuker JH, et al. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet. 2002;39(4):225-42. [
DOI:10.1136/jmg.39.4.225] [
PMID] [
]
6. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8(10):843-54.
7. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88. [
DOI:10.1146/annurev.pharmtox.45.120403.095857] [
PMID]
8. Atkinson HJ, Babbitt PC. Glutathione transferases are structural and functional outliers in the thioredoxin fold. Biochemistry. 2009;48(46):11108-16. [
DOI:10.1021/bi901180v] [
PMID] [
]
9. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev. 2001;10(3):229-36.
10. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272(15):10004-12. [
DOI:10.1074/jbc.272.15.10004] [
PMID]
11. Xue CX, He XM, Zou DH. Glutathione S-transferase M1 Polymorphism and Breast Cancer Risk: a Meta-Analysis in the Chinese Population. Clin Lab. 2016;62(11):2277-2284. [
DOI:10.7754/Clin.Lab.2016.160333] [
PMID]
12. Kuang M, Xu W, Cao CX, Shen LL, Chang J, Zhang XL, et al. Glutathione S-transferase P1 rs1695 A>G polymorphism and breast cancer risk: evidence from a meta-analysis. Genet Mol Res. 2016;15(2). [
DOI:10.4238/gmr.15027771]
13. Song Z, Shao C, Feng C, Lu Y, Gao Y, Dong C. Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis. Ther Clin Risk Manag. 2016;12:763-9. [
DOI:10.2147/TCRM.S104339] [
PMID] [
]
14. Tang J, Zhou Q, Zhao F, Wei F, Bai J, Xie Y, Huang Y. Association of glutathione S-transferase T1, M1 and P1 polymorphisms in the breast cancer risk: a meta-analysis in Asian population. Int J Clin Exp Med. 2015;8(8):12430-47.
15. Xiao ZS, Li Y, Guan YL, Li JG. GSTT1 polymorphism and breast cancer risk in the Chinese population: an updated meta-analysis and review. Int J Clin Exp Med. 2015;8(5):6650-7.
16. Nasr AS, Sami RM, Ibrahim NY, Darwish DO. Glutathione S transferase (GSTP 1, GSTM 1, and GSTT 1) gene polymorphisms in Egyptian patients with acute myeloid leukemia. Indian J Cancer. 2015;52(4):490-5. [
DOI:10.4103/0019-509X.178408] [
PMID]
17. Gulyan IS, Bystritskaya EP, Chernysheva NY, Eliseeva EV, Apanasevich VI, Isaeva MP. Deletion polymorphism of glutathione S-transferases genes (GSTT1, GSTM1) in patients with breast cancer in Primorye region. Tumors female reproduct sys. 2020;16(3):25-31. [
DOI:10.17650/1994-4098-2020-16-3-25-31]
18. Li S, Lang GT, Zhang YZ, Yu KD, Shao ZM, Zhang Q. Interaction between glutathione S-transferase M1-null/present polymorphism and adjuvant chemotherapy influences the survival of breast cancer. Cancer Med. 2018;7(9):4202-4207. [
DOI:10.1002/cam4.1567] [
PMID] [
]
19. Hashemi M, Eskandari-Nasab E, Fazaeli A, Taheri M, Rezaei H, Mashhadi M, et al. Association between polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer risk in a sample Iranian population. Biomark Med. 2012;6(6):797-803. [
DOI:10.2217/bmm.12.61] [
PMID]
20. Sharma A, Pandey A, Sharma S, Chatterjee I, Mehrotra R, Sehgal A, Sharma JK. Genetic polymorphism of glutathione S-transferase P1 (GSTP1) in Delhi population and comparison with other global populations. Meta Gene. 2014;2:134-42. [
DOI:10.1016/j.mgene.2013.12.003] [
PMID] [
]
21. Farmohammadi A, Arab-Yarmohammadi V, Ramzanpour R. Association analysis of rs1695 and rs1138272 variations in GSTP1 gene and breast cancer susceptibility. Asian Pac J Cancer Prev. 2020;21(4):1167-1172. [
DOI:10.31557/APJCP.2020.21.4.1167] [
PMID] [
]
22. Sergentanis TN, Economopoulos KP. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;121(1):195-202. [
DOI:10.1007/s10549-009-0520-0] [
PMID]